| 调脂药物的临床应用 |
| |
| 引用本文： | 刘丽萍. 调脂药物的临床应用[J]. 首都医药, 2014, 0(24): 31-32 |
| |
| 作者姓名： | 刘丽萍 |
| |
| 作者单位： | 天津市滨海新区塘沽中医医院,300451 |
| |
| 摘 要： | 血脂异常是冠心病、心梗和缺血性脑卒中等血管病的重要危险因素。临床研究表明，调脂治疗可以明显降低脂代谢紊乱患者的病死率，减少冠心病发病率。临床常用调脂药物包括他汀类；贝特类；胆固醇吸收抑制剂；烟酸类；胆酸结合树脂；多烯脂肪酸类。
|
| 关 键 词： | 调脂药物 分类 临床应用 |
Clinical use of Lipid regulating drugs |
| |
| Liu Liping. Clinical use of Lipid regulating drugs[J]. Capital Medicine, 2014, 0(24): 31-32 |
| |
| Authors: | Liu Liping |
| |
| Affiliation: | Liu Liping( Tianjin Binhai Distract,Tanggu Chinesemedicine hospital,Tianjin, 300451 China) |
| |
| Abstract: | Study the clinical use of lipid regulating drugs. Dyslipidemia is the k factor for coronary heart myocardial infarction and ey risk disease, ischemic stroke and other cardiovascular disease. Clinical trial studies have shown that lipid adjusting treatment can obviously reduce case fatality rate of lipid metab disorder patients, reduce the olic the incidence of coronary heart disease （CHD）. Clinical commonly used lipid regulating drugs include： （1） The statin drugs; （2） Fibrates; （3） Cholesterol absorption inhibitor. （4） The nicotinic acid ; （5） Bile acid binding resin, （6） Polyene fatty acid. |
| |
| Keywords: | Lipid regulating drugs Sorting Clinical usage |
| 本文献已被 维普 等数据库收录！ |
|
